Literature DB >> 6694262

Rubella virus 40S genome RNA specifies a 24S subgenomic mRNA that codes for a precursor to structural proteins.

C Oker-Blom, I Ulmanen, L Kääriäinen, R F Pettersson.   

Abstract

We have analyzed the structure of the rubella virus genome RNA and the virus-specific RNA species synthesized in B-Vero cells infected with rubella virus. A single-stranded, capped, and polyadenylated RNA species sedimenting at 40S in a sucrose gradient was released from purified virions treated with sodium dodecyl sulfate. This RNA species migrated with an Mr of about 3.8 X 10(6) in an agarose gel after denaturation with glyoxal and dimethyl sulfoxide. Infected cells labeled with [3H]uridine in the presence of actinomycin D contained, in addition to the 40S RNA, a single-stranded polyadenylated 24S RNA species as shown by sucrose gradient analysis. In a Northern blot analysis, this RNA hybridized to a cDNA probe derived from the 3' portion of the genomic 40S RNA. In vitro translation of the 24S RNA species yielded a 110,000-dalton polypeptide, in addition to some smaller products which were immunoprecipitated with an antiserum prepared against the structural proteins E1, E2a, E2b, and C. Since the sum of the molecular weights of the nonglycosylated envelope proteins and the capsid protein has been estimated to be about 116,000 (C. Oker-Blom et al., J. Virol. 46:964-973, 1983), these results suggest that the 24S RNA species represents a subgenomic mRNA coding for a precursor (p110) to the structural proteins of rubella virus. Thus, the strategy of gene expression of rubella virus appears to be similar to that of the alphaviruses.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6694262      PMCID: PMC255479     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  21 in total

1.  A method for determining the sedimentation behavior of enzymes: application to protein mixtures.

Authors:  R G MARTIN; B N AMES
Journal:  J Biol Chem       Date:  1961-05       Impact factor: 5.157

2.  5'-terminus of Moloney murine leukemia virus 35s RNA is m7G5' ppp5' GmpCp.

Authors:  J K Rose; W A Haseltine; D Baltimore
Journal:  J Virol       Date:  1976-10       Impact factor: 5.103

3.  A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.

Authors:  W M Bonner; R A Laskey
Journal:  Eur J Biochem       Date:  1974-07-01

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Infectivity and some physicochemical characteristics of rubella virus ribonucleic acid.

Authors:  T Hovi; A Vaheri
Journal:  Virology       Date:  1970-09       Impact factor: 3.616

6.  Immunochemical identification of rubella virus hemagglutinin.

Authors:  M N Waxham; J S Wolinsky
Journal:  Virology       Date:  1983-04-15       Impact factor: 3.616

7.  Analysis of single- and double-stranded nucleic acids on polyacrylamide and agarose gels by using glyoxal and acridine orange.

Authors:  G K McMaster; G G Carmichael
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

8.  Togaviridae.

Authors:  J S Porterfield; J Casals; M P Chumakov; S Y Gaidamovich; C Hannoun; I H Holmes; M C Horzinek; M Mussgay; N Oker-Blom; P K Russell; D W Trent
Journal:  Intervirology       Date:  1978       Impact factor: 1.763

9.  Nucleic acid of rubella virus and its replication in hamster kidney cells.

Authors:  W D Sedwick; F Sokol
Journal:  J Virol       Date:  1970-04       Impact factor: 5.103

10.  Rubella virus contains one capsid protein and three envelope glycoproteins, E1, E2a, and E2b.

Authors:  C Oker-Blom; N Kalkkinen; L Kääriäinen; R F Pettersson
Journal:  J Virol       Date:  1983-06       Impact factor: 5.103

View more
  39 in total

1.  Role of rubella virus glycoprotein domains in assembly of virus-like particles.

Authors:  M Garbutt; L M Law; H Chan; T C Hobman
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

Review 2.  Rubella virus replication and links to teratogenicity.

Authors:  J Y Lee; D S Bowden
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

3.  Cellular and humoral immune responses to rubella virus structural proteins E1, E2, and C.

Authors:  H H Chaye; C A Mauracher; A J Tingle; S Gillam
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

4.  The E2 signal sequence of rubella virus remains part of the capsid protein and confers membrane association in vitro.

Authors:  M Suomalainen; H Garoff; M D Baron
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

5.  A single-amino-acid substitution of a tyrosine residue in the rubella virus E1 cytoplasmic domain blocks virus release.

Authors:  J Yao; S Gillam
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

6.  Role of N-linked oligosaccharides in processing and intracellular transport of E2 glycoprotein of rubella virus.

Authors:  Z Qiu; T C Hobman; H L McDonald; N O Seto; S Gillam
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

7.  Rubella virus capsid protein structure and its role in virus assembly and infection.

Authors:  Vidya Mangala Prasad; Steven D Willows; Andrei Fokine; Anthony J Battisti; Siyang Sun; Pavel Plevka; Tom C Hobman; Michael G Rossmann
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-26       Impact factor: 11.205

Review 8.  Molecular and Structural Insights into the Life Cycle of Rubella Virus.

Authors:  Pratyush Kumar Das; Margaret Kielian
Journal:  J Virol       Date:  2021-02-24       Impact factor: 5.103

9.  Construction of rubella virus genome-length cDNA clones and synthesis of infectious RNA transcripts.

Authors:  C Y Wang; G Dominguez; T K Frey
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

10.  Expression and characterization of virus-like particles containing rubella virus structural proteins.

Authors:  Z Qiu; D Ou; T C Hobman; S Gillam
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.